Find out more about Emma Link's experience
Emma Link's highlights
FEATURED Journal article
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Read moreEmma Link's selected work
A RANDOMISED PHASE III STUDY OF RADIATION DOSES AND FRACTIONATION SCHEDULES FOR NON-LOW RI..
Research Grant
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone ..
Journal article
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? -..
Journal article
1670P Circulating tumor DNA (ctDNA) dynamics of response and resistance in BRAF V600E muta..
Journal article
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in th..
Journal article
Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP..
Journal article
Emma Link's selected work
Projects
Displaying the 1 most recent project from 1 for Emma Link.
Project Types
1
Research Grant
Scholarly Works
Displaying the 10 most recent scholarly works from 52 for Emma Link.
Keyword Analysis
Credentials
Positions
Honorary
The Sir Peter Maccallum Department of Oncology
Education
Doctorate of Philosophy
University of Oxford
Honours degree of Bachelor of Science (Science Scholar Program)
Monash University